Moderna Stock Drops 25% After Cancer Vaccine Data Leak
Photo: Watcher Guru
The Moderna stock drop on Thursday, October 22, reached as much as 25% after partial data on the Merck Moderna cancer vaccine leaked on an oncology website ahead of its official release. It was an odd Moderna stock plunge, since the Moderna cancer vaccine actually delivered good news, cutting the risk of melanoma recurrence or death by 42% when paired with Merck’s Keytruda. By the close, the Moderna stock price had settled at $202.63 , down $43.18 or 17.57%.
Source: Watcher Guru
